Yuji Aoki. 2016. “Comparison of Diuretic Effects Between Empagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor With Osmotic Diuresis, and Tolvaptan, a Water Diuretic, in Two Type 2 Diabetic Patients Taking Sodium Diuretics”. Diabetes Research 2 (2):45-49. https://openventio.us/index.php/DR/article/view/1621.